Back to
DEUTSCHE BANK AG\
ACRSShowing 8 of 31 quarters
Position history for
DEUTSCHE BANK AG\'s holdings in ACLARIS THERAPEUTICS INC
Yes. Deutsche Bank holds 1,040,955 shares of ACRS (Aclaris Therapeutics), worth $5.5M, as of its Q2 2026 13F filing. It increased the position by 43,105 shares (+4.3%) from Q1 2026. Deutsche Bank has held ACRS in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$5.5M
Current Shares
1M
Total Value Change
+$4.4M
Total Shares Change
+117,642
Quarter-by-Quarter History
Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP